By 2028, the revenue of the global parenteral product packaging market will reach 20.867.6 billion U.S. dollars; the demand for injection drugs for the treatment of different diseases will continue to increase to drive market growth – QNT Press Release


New York, December 7, 2021 (Global News Agency)- The American Cancer Institute stated in one of its statistics that in 2018, the number of newly diagnosed cancer cases worldwide was 17,036,901, of which breast cancer and lung cancer were the most common cancer diseases, accounting for 12.3 share. Respectively as a percentage of total cancer cases. In addition, according to the World Health Organization (WHO), by 2020, the total number of cancer-related deaths is approximately 10 million. Among them, lung cancer and colorectal cancer are the most common, with 1.8 million deaths and 930,000 deaths recorded in the same year respectively.

Research Nester recently published a report on “Global parenteral product packaging market“It provides detailed insights into the growth drivers, opportunities and latest market trends related to market growth during the forecast period (i.e. 2021-2028). The report also includes a brief analysis of the major market operators operating in the market, and They have adopted different growth strategies over the years to stay ahead of the competition.

Parenteral drugs are widely used as chemotherapeutics for the treatment of cancer diseases. With the global increase in cancer incidence, the demand for these drugs has increased dramatically over the years. However, these products need to be handled carefully during the packaging process to maintain the integrity of the pharmaceutical ingredients in the drug, which is expected to promote the growth of the global injectable product market during the forecast period. The market received a revenue of US$9.0026 billion in 2019 and is expected to reach US$20.86 billion by the end of 2028, growing at a compound annual growth rate of 8.8% during the forecast period. Due to the increasing incidence of diabetes, the demand for parenteral insulin is increasing, and the market is expected to grow. In other WHO statistics, about 1.5 million people died directly from diabetes in 2019. In addition, the growing concern for chronic diseases and the increasing global demand for different types of vaccines are some of the additional factors. Factors that are expected to drive market growth. According to the Centers for Disease Control and Prevention (CDC), 6 out of every 10 Americans are known to have chronic diseases, including cancer, diabetes, heart disease and stroke. In addition, the increase in health care expenditures is also expected to drive the demand for injection products, which in turn promotes the market growth of injection product packaging. The World Bank stated in one of its statistics that the current global health expenditure as a proportion of GDP has risen from 8.687% in 2000 to 9.857% in 2018.

Get a sample copy of the report@

The global parenteral product packaging market is divided into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa by region. Among them, the North American market is expected to occupy the highest market share during the entire forecast period, and will receive the largest market revenue of US$6.934 billion by the end of 2028, which is higher than the US$2.9661 billion in 2019. The market in this region is also expected to follow…

The full story can be found on


Source link

Recommended For You

About the Author: News Center